Diffuse follicle center lymphoma, in remission is a subtype of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes in the follicle center. This condition is clinically significant as it indicates a stage where the disease has responded to treatment, allowing for better management and monitoring. The ICD-10 Code C82.5A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.
ICD-10 Code C82.5A represents Diffuse follicle center lymphoma, in remission, a condition where malignant B-cells are present but have responded to treatment, leading to a reduction or absence of symptoms. This code is used in clinical documentation and billing to indicate the patient's current status, ensuring appropriate treatment plans and follow-up care are established.
Diffuse follicle center lymphoma, in remission, is a hematological malignancy arising from the transformation of B-lymphocytes in the germinal centers of lymphoid tissue. The condition requires ongoing medical attention due to its potential for recurrence and the need for monitoring after treatment.
ICD-10 Code C82.5A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers can track the patient's progress and adjust therapies as necessary.
In SOAP notes, ICD-10 Code C82.5A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Diffuse follicle center lymphoma, in remission focuses on monitoring and supportive care to prevent recurrence.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.5A is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description | 
|---|---|
| 99213 | Established patient office visit, low complexity. | 
| 85025 | Complete blood count with differential. | 
| 36415 | Collection of venous blood by venipuncture. | 
Common Questions About Using ICD-10 Code C82.5A for Diffuse follicle center lymphoma, in remission
What does it mean for Diffuse follicle center lymphoma to be in remission?
Being in remission means that the signs and symptoms of Diffuse follicle center lymphoma have decreased or disappeared following treatment. However, ongoing monitoring is essential as the disease can recur.
How is remission status documented in medical records?
Remission status is documented using ICD-10 Code C82.5A in the patient's medical records, ensuring that healthcare providers are aware of the current state of the disease for treatment planning.
What are the follow-up procedures for patients in remission?
Patients in remission typically require regular follow-up appointments, including physical exams and blood tests, to monitor for any signs of recurrence or complications.
Can patients with Diffuse follicle center lymphoma in remission experience symptoms?
While patients may not exhibit symptoms during remission, they should remain vigilant and report any new or unusual symptoms to their healthcare provider for evaluation.
Clinical Notes
SOAP notes
DAP notes
AI medical notes